Jubilant Ingrevia share price
NSE: JUBLINGREABSE: 543271Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹609.45.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,587 Cr549th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 22 Jul 2026
- 31.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 22 Jul 2026
- 10.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 22 Jul 2026
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,85,55457.7% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 22 Jul
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,300 Crup 10.32%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹106 Crup 22.42%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 8.1%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 24 Oct | Dec 2024Filed 29 Jan | Mar 2025Filed 10 Jun | Jun 2025Filed 31 Jul | Sep 2025Filed 4 Nov | Dec 2025Filed 4 Feb | Mar 2026Filed 26 May | Jun 2026Filed 22 Jul |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 |
| Net profit | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 5.6% | 6.6% | 7.0% | 7.2% | 6.2% | 4.5% | 7.3% | 8.1% |
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Speciality ChemicalsSpeciality Chemicals, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹2,214 Crup 7.44%47.4%
- Chemical IntermediatesChemical Intermediates, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1,668 Crup 2.86%35.7%
- Nutrition & Health SolutionsNutrition & Health Solutions, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹790 Crup 5.67%16.9%
Valuation
Today, against the company's own history.PE ratio and valuation history
At or below today's level on 42% of 1,171 trading days since Feb 2022.
At or below today's level on 30% of 1,240 trading days over the last 5 years.
At or below today's level on 39% of 1,171 trading days since Feb 2022.
At or below today's level on 59% of 1,240 trading days over the last 5 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −15.4% | +10.7% | −24.4% | 0.9% |
| 3 years | +15.7% | −3.1% | +18.4% | 0.9% |
| 5 years | +17.0% | +38.6% | −16.4% | 1.1% |
Mutual funds holding it
79 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 40 of the 45 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 1 more fund filed its first portfolio on record, holding it.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 3
- AddedAdded. Funds that held more shares than at the end of the month before.
- 16
- CutCut. Funds that held fewer shares than at the end of the month before.
- 29
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 30
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 2
| Fund | |||
|---|---|---|---|
 DSP Small Cap FundDSP Mutual Fund | 60,02,947 | 1.83% | ₹392.1 Cr |
 Bandhan Small Cap FundBandhan Mutual Fund | 36,32,989 | 0.66% | ₹237.3 Cr |
 Kotak-Small Cap FundKotak Mahindra Mutual Fund | 36,29,417 | 1.24% | ₹237.1 Cr |
 Franklin India Small Cap FundFranklin Templeton Mutual Fund | 32,97,920 | 1.51% | ₹215.4 Cr |
 Axis Small Cap FundAxis Mutual Fund | 31,11,670 | 0.66% | ₹203.3 Cr |
| DSP Midcap FundDSP Mutual Fund | 28,87,680 | 0.97% | ₹188.6 Cr |
 Edelweiss Small Cap FundEdelweiss Mutual Fund | 14,24,301 | 1.33% | ₹93.0 Cr |
 HDFC Manufacturing fundHDFC Mutual Fund | 12,05,150 | 0.77% | ₹78.7 Cr |
 UTI Small Cap FundUTI Mutual Fund | 11,71,620 | 1.46% | ₹76.5 Cr |
| HDFC Multi Cap FundHDFC Mutual Fund | 11,00,000 | 0.37% | ₹71.9 Cr |
Peers and competitors
Specialty Chemicals, 130 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Jubilant Ingrevia in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Anupam Rasayan IndiaANURAS | 12,542 | 71.8 | 3.8 | 24.8 | +51.8% | +41.5% | 5.7% | 6.2% | 0.14% |
 Vinati OrganicsVINATIORGA | 11,102 | 24.8 | 3.5 | 16.7 | +5.1% | +5.4% | 15.1% | 17.3% | 0.79% |
 Sudeep PharmaSUDEEPPHRM | 10,913 | 59.7 | 12.4 | 47.0 | – | – | 20.7% | 20.8% | 0.16% |
 Elantas Beck IndiaELANTAS | 9,740 | 54.9 | 8.8 | 44.5 | +17.7% | +33.5% | 17.4% | 17.6% | 0.06% |
 Alkyl Amines ChemicalsALKYLAMINE | 8,362 | 37.1 | 5.5 | 23.9 | +5.1% | +20.6% | 15.3% | 17.6% | 0.61% |
 Galaxy SurfactantsGALAXYSURF | 7,877 | 22.3 | 2.9 | 12.9 | +27.1% | +16.1% | 13.9% | 16.2% | 0.99% |
 Clean Science and TechnologyCLEAN | 7,583 | 32.6 | 4.8 | 21.5 | −0.4% | −13.3% | 15.5% | 17.1% | 0.84% |
 Neogen ChemicalsNEOGEN | 6,530 | 183.6 | – | – | +18.0% | +6.0% | 4.4% | 5.8% | 0.05% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.| Ex-date | Type | Per share |
|---|---|---|
| 24 Jul 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.50 |
| 10 Feb 2026 | Interim | ₹2.50 |
| 25 Jul 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.50 |
| 3 Feb 2025 | Interim | ₹2.50 |
| 2 Aug 2024 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.50 |
| 9 Feb 2024 | Interim | ₹2.50 |
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
14 Oct · Analysts
13 Oct · General Updates
1 Oct · Management
Jubilant Ingrevia share price by year
Each calendar year to 2025.Jubilant Ingrevia share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 703.45 | −14.5% | 859.20 | 580.55 |
| 2024 | 823.05 | +61.8% | 849.95 | 426.75 |
| 2023 | 508.60 | −3.8% | 534.25 | 358.50 |
| 2022 | 528.55 | −7.9% | 635.90 | 417.25 |
| 2021 | 573.70 | – | 810.15 | 254.00 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 601.00 | 612.00 | 592.65 | 601.90 | 598.28 | 2,85,554 | 57.7% |
| 22 Oct 2026 | 595.00 | 612.00 | 594.05 | 609.45 | 603.43 | 2,11,983 | 41.8% |
| 21 Oct 2026 | 623.70 | 628.75 | 595.00 | 596.95 | 603.31 | 2,32,353 | 48.8% |
| 19 Oct 2026 | 635.15 | 635.90 | 621.00 | 623.70 | 624.82 | 1,19,235 | 59.0% |
| 16 Oct 2026 | 630.00 | 640.00 | 628.40 | 630.95 | 632.48 | 99,412 | 39.7% |
| 15 Oct 2026 | 648.00 | 648.00 | 629.10 | 632.70 | 637.46 | 91,085 | 43.0% |
| 14 Oct 2026 | 627.50 | 648.00 | 626.00 | 645.25 | 640.39 | 1,74,681 | 51.7% |
| 13 Oct 2026 | 628.50 | 631.45 | 617.40 | 627.50 | 623.13 | 94,896 | 48.8% |
| 12 Oct 2026 | 630.70 | 634.65 | 625.50 | 628.00 | 629.52 | 1,01,423 | 43.1% |
| 9 Oct 2026 | 621.00 | 628.55 | 612.30 | 625.80 | 622.23 | 3,09,836 | 59.3% |
About Jubilant Ingrevia
Jubilant Ingrevia Limited is a specialty chemicals company. It also runs a contract development and manufacturing (CDMO) business, serving pharmaceutical, agrochemical and semiconductor customers. Its customers also include nutrition, consumer and industrial companies. It was incorporated in 2019, and the chemicals business it carries on has more than 45 years of history.
The company reports three segments. Specialty Chemicals covers pyridine and picolines, fine chemicals and CDMO. Nutrition and Health Solutions covers vitamins, choline and premixes for both human and animal nutrition. Chemical Intermediates covers products such as acetic anhydride and ethyl acetate.
It runs more than 50 plants in India, with manufacturing sites at Gajraula in Uttar Pradesh, Bharuch and Nira. Three R&D centres employ 150 scientists, and the company has over 2,300 employees. It serves over 1,600 customers in 63 countries, including the US, the EU, Japan, the Middle East and South East Asia, as well as India. Its registered office is at Gajraula, and its corporate office is in Noida. Its equity shares are traded on the NSE and on BSE.
In the year to March 2026, it acquired Remidex Pharma Private Limited, which has since been integrated. The company's promoters include Shyam S. Bhartia, who is the founder and chairman of Jubilant Bhartia Group. A promoter is the person or group that set up a company or controls it. He also chairs the company's board, and Hari S. Bhartia is its co-chairman.
- Legal name
- Jubilant Ingrevia Limited
- NSE symbol
- JUBLINGREA
- BSE code
- 543271
- ISIN
- INE0BY001018
- Industry
- Chemicals & Petrochemicals
- Listed
- Mar 2021
- Face value
- ₹1
- CIN
- L24299UP2019PLC122657
- Corporate identity number, the registrar of companies' code for it